WHITLEY ROBERTS HARPER: Open Payments
NPI 1528653409 · EVERGREEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 61 payments from 15 companies in 2025. Trend: 2023 $1,523 · 2024 $1,162 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 10 | $177 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| Otsuka America Pharmaceutical, Inc. | 6 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| ABBVIE INC. | 4 | $72 |
| SHIELD THERAPEUTICS INC | 3 | $56 |
| Exact Sciences Corporation | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Axsome Therapeutics, Inc. | 3 | $51 |
Products named: MOUNJARO, TRELEGY ELLIPTA, REXULTI, Kerendia, FARXIGA, VRAYLAR, ACCRUFER, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
